EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Research Progress of Molecular H2 in Mediating Immune Tolerance via Regulating Tregs—from the Perspective of the 2025 Nobel Prize in Physiology or Medicine

Xiaolin Ding, Wenjie Tang iD, Yumei Wang, Jinfeng Tian, Jingfei Shi, Youzhen Wei, Chao Cui iD

Drug Design, Development and Therapy · 2026

DOI: 10.2147/dddt.s640423 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2026. Verfasst von Xiaolin Ding und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Qilu Hospital of Shandong University Dezhou Hospital, Dezhou, Shandong, People's Republic of China. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Nobel Prize, Immune Tolerance, Hydrogen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

T-Lymphocytes, RegulatoryNobel PrizeImmune ToleranceHydrogenHumansAnimalsAutoimmune Diseases

Stichwörter der Autor:innen

FOXP3Treghydrogenimmune toleranceoxidative stress

Substanzen

Hydrogen

Autor:innen und Institutionen

  • Department of Hematology, Qilu Hospital of Shandong University Dezhou Hospital, Dezhou, Shandong, People's Republic of China.
  • State Key Laboratory of Cardiology and Medical Innovation Center, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China.
  • Shanghai Heart Failure Research Center, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China.
  • Department of Cardiovascular Surgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China.
  • Hydrogen Medicine Center, The Affiliated Taian City Central Hospital of Qingdao University, Taian, Shandong, People's Republic of China.
  • Department of Clinical and Basic Medicine, Shandong First Medical University, Jinan, Shandong, People's Republic of China.

ORCID-Profile: Wenjie Tang, Chao Cui

Zitieren

APA

Ding, X., Tang, W., Wang, Y., Tian, J., Shi, J., Wei, Y., & Cui, C. (2026). Research Progress of Molecular H2 in Mediating Immune Tolerance via Regulating Tregs—from the Perspective of the 2025 Nobel Prize in Physiology or Medicine. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s640423

Vancouver

Ding X, Tang W, Wang Y, Tian J, Shi J, Wei Y, et al. Research Progress of Molecular H2 in Mediating Immune Tolerance via Regulating Tregs—from the Perspective of the 2025 Nobel Prize in Physiology or Medicine. Drug Design, Development and Therapy. 2026. doi:10.2147/dddt.s640423

BibTeX
@article{Ding2026,
  author = {Ding, Xiaolin and Tang, Wenjie and Wang, Yumei and Tian, Jinfeng and Shi, Jingfei and Wei, Youzhen and Cui, Chao},
  title = {Research Progress of Molecular H2 in Mediating Immune Tolerance via Regulating Tregs—from the Perspective of the 2025 Nobel Prize in Physiology or Medicine},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  doi = {10.2147/dddt.s640423}
}
Kostenlos starten →